Post-transplant cyclophosphamide-based graft-versus-host disease prophylaxis following mismatched unrelated donor peripheral blood stem cell (PBSC) transplantation

被引：0
|
作者：
Al Malki, Monzr M.
Bo-Subait, Stephanie
Logan, Brent
Olson, Janelle
Leckrone, Erin
Wu, Juan
Stefanski, Heather E.
Auletta, Jeffery J.
Spellman, Stephen R.
Malmberg, Craig
Shaffer, Brian C.
Modi, Dipenkumar
Khimani, Farhad
Gooptu, Mahasweta
Hamadani, Mehdi
Broglie, Larisa
Shaw, Bronwen E.
Devine, Steven Michael
Jimenez, Antonio Martin Jimenez
机构：
[1] City Hope Natl Med Ctr, Duarte, CA USA
[2] NMDP, CIBMTR, Minneapolis, MN USA
[3] Med Coll Wisconsin, Div Biostat, Milwaukee, WI USA
[4] Mem Sloan Kettering Canc Ctr, New York, NY USA
[5] Wayne State Univ, Barbara Ann Karmanos Canc Inst, Detroit, MI USA
[6] H Lee Moffitt Canc Ctr & Res Inst, Dept Blood & Marrow Transplantat & Cellular Immun, Tampa, FL USA
[7] Dana Farber Canc Inst, Dept Hematol Oncol, Boston, MA USA
[8] Med Coll Wisconsin, CIBMTR, Milwaukee, WI USA
[9] Med Coll Wisconsin, CIBMTR, Dept Med, Milwaukee, WI USA
[10] Univ Miami, Sylvester Comprehens Canc Ctr, Miller Sch Med, Miami, FL USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6503
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Antithymocyte globulin plus post-transplant cyclophosphamide combination as graft-versus-host disease prophylaxis in haploidentical peripheral blood stem cell transplantation for hematological malignancies
    Tzu-Ting Chen
    Ching-Chan Lin
    Wen-Jyi Lo
    Ching-Yun Hsieh
    Ming-Yu Lien
    Che-Hung Lin
    Chen-Yuan Lin
    Li-Yuan Bai
    Chang-Fang Chiu
    Su-Peng Yeh
    International Journal of Hematology, 2022, 115 : 525 - 533
  • [22] PTCy versus ATG as graft-versus-host disease prophylaxis in mismatched unrelated stem cell transplantation
    Olaf Penack
    Mouad Abouqateb
    Christophe Peczynski
    William Boreland
    Zafer Gülbas
    Tobias Gedde-Dahl
    Cristina Castilla-Llorente
    Nicolaus Kröger
    Mathias Eder
    Alessandro Rambaldi
    Francesca Bonifazi
    Igor Wolfgang Blau
    Matthias Stelljes
    Peter Dreger
    Ivan Moiseev
    Hélène Schoemans
    Christian Koenecke
    Zinaida Peric
    Blood Cancer Journal, 14
  • [23] A Phase II Clinical Trial of Post-Transplant Cyclophosphamide for Graft Versus Host Disease Prevention Following Myeloablative Peripheral Blood Stem Cell Matched Unrelated Donor Hematopoietic Stem Cell Transplantation
    Jamy, Omer
    Innis-Shelton, Racquel
    Bal, Susan
    Salzman, Donna
    Costa, Luciano J.
    di Stasi, Antonio
    Lamb, Lawrence
    Mineishi, Shin
    Saad, Ayman
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2020, 26 (03) : S190 - S191
  • [24] A Phase II Clinical Trial of Post-Transplant Cyclophosphamide for Graft Versus Host Disease Prevention Following Myeloablative Peripheral Blood Stem Cell Matched Unrelated Donor Hematopoietic Stem Cell Transplantation
    Jamy, Omer
    Innis-Shelton, Racquel
    Bal, Susan
    Paluri, Ravi K.
    Karim, Samina
    Chewning, Joseph H.
    Salzman, Donna
    Costa, Luciano J.
    Di Stasi, Antonio
    Lamb, Lawrence S., Jr.
    Mineishi, Shin
    Saad, Ayman
    BLOOD, 2019, 134
  • [25] PTCy versus ATG as graft-versus-host disease prophylaxis in mismatched unrelated stem cell transplantation
    Penack, Olaf
    Abouqateb, Mouad
    Peczynski, Christophe
    Boreland, William
    Gulbas, Zafer
    Gedde-Dahl, Tobias
    Castilla-Llorente, Cristina
    Kroeger, Nicolaus
    Eder, Mathias
    Rambaldi, Alessandro
    Bonifazi, Francesca
    Blau, Igor Wolfgang
    Stelljes, Matthias
    Dreger, Peter
    Moiseev, Ivan
    Schoemans, Helene
    Koenecke, Christian
    Peric, Zinaida
    BLOOD CANCER JOURNAL, 2024, 14 (01)
  • [26] Impact of Graft Cell Dose on Outcomes after Haploidentical Peripheral Blood Stem Cell Transplantation with Post-Transplant Cyclophosphamide-Based Gvhd Prophylaxis
    Mushtaq, Muhammad Umair
    Kasaeian, Amir
    Chaudhary, Sibgha Gull
    Amin, Muhammad Kashif
    Anwar, Iqra
    Alemi, Hediyeh
    Khavandgar, Naghmeh
    Mohsin, Aleenah
    Mcguirk, Matthew
    Abhyankar, Sunil
    Hamadani, Mehdi
    Mcguirk, Joseph P.
    Shahzad, Moazzam
    BLOOD, 2024, 144 : 7278 - 7279
  • [27] Post-Transplant Cyclophosphamide, Abatacept and Short Course of Tacrolimus (CAST) for Graft-Versus-Host Disease Prevention Following Haploidentical Peripheral Blood Stem Cell Transplantation
    Al-Homsi, A. Samer
    Cirrone, Frank
    Cole, Kelli
    Suarez-Londono, Jaime Andres
    Gardner, Sharon L.
    Hsu, Jingmei
    Wo, Stephanie
    Stocker, Kelsey
    Bruno, Benedetto
    Goldberg, Judith
    Levinson, Benjamin
    Abdul-Hay, Maher
    BLOOD, 2022, 140 : 7628 - 7630
  • [28] Post-transplant cyclophosphamide as graft-versus-host disease prophylaxis in HLA matched sibling donor stem cell transplantation for patients with acute leukemia.
    Elshamy, Alaa Nabil
    Abdelmohsen, Essam Ali
    Denewer, Mai
    Mabed, Mohamed Nasr
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [29] Reply to: Disparities in Allograft Access in the Era of Post-Transplant Cyclophosphamide-Based Mismatched Unrelated Donor Transplantation
    Shaffer, Brian C.
    Gooptu, Mahasweta
    Defor, Todd
    Spellman, Stephen R.
    Stefanski, Heather E.
    Shaw, Bronwen E.
    Auletta, Jeffery J.
    Devine, Steven M.
    Jimenez, Antonio M.
    Al Malki, Monzr M.
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (04) : 476 - 478
  • [30] Post-transplant cyclophosphamide and sirolimus based graft-versus-host disease prophylaxis after allogeneic stem cell transplantation for acute myeloid leukemia
    Lazzari, Lorenzo
    Balaguer-Rosello, Aitana
    Montoro, Juan
    Greco, Raffaella
    Hernani, Rafael
    Lupo-Stanghellini, Maria Teresa
    Villalba, Marta
    Giglio, Fabio
    Facal, Ana
    Lorentino, Francesca
    Guerreiro, Manuel
    Bruno, Alessandro
    Perez, Ariadna
    Xue, Elisabetta
    Clerici, Daniela
    Piemontese, Simona
    Luis Pinana, Jose
    Angel Sanz, Miguel
    Solano, Carlos
    de la Rubia, Javier
    Ciceri, Fabio
    Peccatori, Jacopo
    Sanz, Jaime
    BONE MARROW TRANSPLANTATION, 2022, 57 (09) : 1389 - 1398
12345